Skip to main content
. 2014 Nov 13;11:188. doi: 10.1186/s12974-014-0188-1

Table 3.

Frequency of cerebrospinal fluid (CSF) and serum samples with detectable levels of anti-Epstein Barr nuclear antigen 1 (EBNA-1) and anti-viral capsid antigen (VCA) IgG in patients with relapsing-remitting multiple sclerosis (RRMS), other inflammatory neurological disorders (OIND) and noninflammatory neurological disorders (NIND)

Anti-EBNA-1 IgG Anti-VCA IgG
CSF Serum CSF Serum
RRMS (n = 100) 96/100 (96%)a 99/100 (99%) 65/100 (65%) 90/100 (90%)
OIND (n = 100) 91/100 (91%) 96/100 (96%) 86/100 (86%)b 94/100 (94%)
NIND (n = 100) 86/100 (86%) 94/100 (94%) 74/100 (74%) 90/100 (90%)

CSF anti-EBNA-1 IgG (Chi-square with Bonferroni correction): aRRMS versus NIND (P <0.05); CSF anti-VCA IgG (Chi-square with Bonferroni correction): bOIND versus RRMS (P <0.001).